Target intelligence / Profile preview

Hemagglutinin protein of influenza A virus subtype H10N8 (HA)

Target
HA
Molecular classification
Glycoprotein, Fusion protein, Receptor-binding protein
01

Overview

The Hemagglutinin protein of influenza A virus subtype H10N8 is a homotrimeric integral membrane glycoprotein that functions as both an attachment factor and class I fusion protein. It binds sialic acid-containing receptors on host cells via its globular head domain (comprising receptor-binding domain, vestigial esterase domain), enabling viral attachment, and mediates low-pH-induced membrane fusion through its stem domain (fusion peptide, ectodomain, transmembrane anchor) for viral entry. Synthesized as inactive HA0 precursor, it is cleaved into HA1 (head) and HA2 (stem) subunits linked by disulfide bonds. H10N8 subtype HA contributes to host specificity and is a key target for neutralizing antibodies and vaccines, with structural conservation in the stalk but variability in the head.

Other names
HA proteinInfluenza hemagglutininHA glycoprotein
02

Mechanism of action

Neutralization by binding receptor-binding domain (RBD) to block sialic acid attachment, Inhibition of conformational change in stalk to prevent membrane fusion

03

Biological functions

Receptor bindingMembrane fusionViral attachmentViral entry
04

Disease associations

Infection
05

Safety considerations

Antigenic drift in receptor-binding domain leading to immune escapeGlycosylation changes shielding antigenic sites
06

Interacting drugs

C05 antibody

4 more in the full profile.

Beyond the preview

Go deeper on Hemagglutinin protein of influenza A virus subtype H10N8 (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein of influenza A virus subtype H10N8 (HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call